What is Biovie Inc's earnings per share (EPS)?

Biovie Inc (BIVIW) reported diluted earnings per share of -$3.05 for fiscal year 2026. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Biovie Inc (BIVIW) Financials

BIVIW

FY2026 annual

Revenue Not reported for FY2026

Net Income -$22.1M -25.8% YoY

EPS (Diluted) -$3.05 YoY not available

Operating Cash Flow -$19.0M 0.0% YoY

Source SEC Filings (10-K/10-Q) Latest period FY2026, ended Jun 30, 2026 Reported Aug 13, 2026 Currency USD FYE June

Newest figures come from the 10-K for FY2026, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BIVIW SEC filings page.

This page shows Biovie Inc (BIVIW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial health score not available

Biovie Inc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

1/6

Biovie Inc passes 1 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).

Earnings Quality No Cash Backing

N/A

Biovie Inc reported a net loss of $22.1M while operations used $19.0M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Biovie Inc reported an operating loss of $22.7M against $18K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

EPS (Diluted)

-$0.70

YoY+51.4%

QoQ0.0%

Biovie Inc earned -$0.70 per diluted share (EPS) in Q4 2026. This represents an increase of 51.4% from the same quarter a year earlier. It is unchanged from the prior quarter.

Revenue

Not reported for Q4 2026.

EBITDA

Not reported for Q4 2026.

Net Income

Not reported for Q4 2026.

Cash & Balance Sheet

Cash & Debt

$9.0M

YoY-48.8%

QoQ-31.5%

5Y CAGR+14.8%

10Y CAGR+53.5%

Biovie Inc held $9.0M in cash as of Q4 2026; long-term debt is not reported for that period.

Shares Outstanding

YoY+0.1%

QoQ0.0%

5Y CAGR-21.2%

10Y CAGR-21.7%

Biovie Inc had 8M shares outstanding in Q4 2026. This represents an increase of 0.1% from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q4 2026.

Dividends Per Share

Not reported for Q4 2026.

Margins & Returns

None of these metrics is reported for Q4 2026.

Capital Allocation

None of these metrics is reported for Q4 2026.

BIVIW Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BIVIW quarterly income statement

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1410-K
R&D Expenses	$14.0M+50.7%	$9.3M-59.9%	$23.1M-30.6%	$33.3M+92.9%	$17.3M+578.2%	$2.5M+121.2%	$1.2M+14.1%	$1.0M+171.8%	$371K-20.5%	$466K+1130.5%	$38K+803.3%	$4K-91.5%	$49K	$49K
SG&A Expenses	$8.5M-0.7%	$8.6M-3.2%	$8.8M-23.4%	$11.6M+18.3%	$9.8M+110.6%	$4.6M+253.2%	$1.3M+4.3%	$1.3M-28.9%	$1.8M+2463.5%	$69K+351.2%	$15K-7.0%	$16K-36.4%	$26K	$117K
Operating Income	-$22.7M-25.4%	-$18.1M+43.9%	-$32.2M+28.6%	-$45.1M-65.4%	-$27.3M	N/A	-$2.7M-7.9%	-$2.5M-5.2%	-$2.4M-52.7%	-$1.6M-259.6%	-$432K-85.1%	-$233K	N/A	N/A
Interest Expense	$18K-94.6%	$333K-88.5%	$2.9M-32.7%	$4.3M+98.8%	$2.2M+286.6%	$559K-88.3%	$4.8M+1748042.5%	$273-99.3%	$41K	N/A	$81	N/A	N/A	N/A
Net Income	-$22.1M-25.8%	-$17.5M+45.4%	-$32.1M+36.1%	-$50.3M-92.7%	-$26.1M	N/A	N/A	-$2.4M-0.4%	-$2.4M-82.9%	-$1.3M-208.1%	-$432K-85.4%	-$233K+27.6%	-$322K	-$166K
EPS (Basic)	-$3.05+74.8%	-$12.12+83.4%	-$73.05-372.2%	-$15.47-1359.4%	-$1.06+92.8%	-$14.82-116.4%	-$6.85-599.0%	-$0.98	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	-$3.05	-$12.12	-$73.05	-$15.47	-$1.06+92.8%	-$14.82	-$6.85	-$0.98	N/A	N/A	N/A	N/A	N/A	N/A
Diluted Shares (Avg)	7M	1M	451,853	3M	25M+98.8%	12M	5M	3M	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'2610-K	Q3'2610-K	Q2'2610-K	Q1'2610-K	Q4'2510-K	Q3'2510-K	Q2'2510-K	Q1'2510-K
R&D Expenses	N/A	$3.2M+136.2%	$4.3M-9.3%	$2.9M+47.5%	N/A	$1.3M-76.4%	$4.7M-27.3%	$2.0M-77.6%
SG&A Expenses	N/A	$2.2M+35.6%	$1.9M-23.5%	$2.3M+10.4%	N/A	$1.6M-19.7%	$2.5M+12.3%	$2.1M+6.8%
Operating Income	N/A	-$5.4M-80.2%	-$6.3M+14.1%	-$5.3M-28.2%	N/A	-$3.0M+61.4%	-$7.3M+17.0%	-$4.1M+62.1%
Interest Expense	N/A	$6K+19.4%	$6K-91.1%	$2K-99.2%	N/A	$5K-99.2%	$67K-91.9%	$256K-74.5%
Net Income	N/A	-$5.3M-89.0%	-$6.1M+14.7%	-$5.1M-22.5%	N/A	-$2.8M+65.4%	-$7.1M+15.3%	-$4.2M+61.2%
EPS (Basic)	-$0.70+51.4%	-$0.70+53.6%	-$0.77+83.1%	-$0.98+86.0%	-$1.44+97.8%	-$1.51+24.5%	-$4.55-106.8%	-$7.00-139.7%
EPS (Diluted)	-$0.70+51.4%	-$0.70	-$0.77	-$0.98	-$1.44+97.8%	-$1.51	-$4.55	-$7.00
Diluted Shares (Avg)	N/A	8M	8M	5M	N/A	2M	2M	639,836

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, EBITDA, Income Tax.

BIVIW Balance Sheet

BIVIW quarterly balance sheet

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1410-K
Total Assets	$14.3M-33.9%	$21.6M-14.5%	$25.2M-28.2%	$35.1M+74.5%	$20.1M+232.7%	$6.0M+190.2%	$2.1M-19.1%	$2.6M+18.3%	$2.2M-8.0%	$2.4M-13.1%	$2.7M+909.0%	$269K-19.0%	$333K	$360K
Current Assets	$13.6M-34.1%	$20.7M-13.9%	$24.0M-29.4%	$34.0M+81.3%	$18.8M+307.8%	$4.6M+1015.1%	$413K-38.7%	$674K+1371.8%	$46K+791.1%	$5K-96.1%	$131K-51.5%	$269K-19.0%	$333K	$360K
Cash & Equivalents	$9.0M-48.8%	$17.5M-26.4%	$23.8M+22.5%	$19.5M+4.4%	$18.6M+313.2%	$4.5M+12029.7%	$37K-89.1%	$340K+642.2%	$46K+791.1%	$5K-95.8%	$124K-53.7%	$267K-19.6%	$333K	$345K
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	N/A
Goodwill	$346K0.0%	$346K0.0%	$346K0.0%	$346K0.0%	$346K0.0%	$346K0.0%	$346K0.0%	$346K0.0%	$346K0.0%	$346K0.0%	$346K	N/A	N/A	N/A
Total Liabilities	$4.0M+56.1%	$2.6M-73.7%	$9.7M-50.9%	$19.8M+20.2%	$16.4M+1550.4%	$996K-95.8%	$23.6M+5217.6%	$443K-78.5%	$2.1M+71.0%	$1.2M+50.3%	$803K+148.2%	$324K+100.4%	$161K	$3K
Current Liabilities	$3.8M+66.9%	$2.3M-75.7%	$9.4M-35.5%	$14.5M+247.7%	$4.2M+318.4%	$996K-95.8%	$23.5M+5203.5%	$443K-64.2%	$1.2M+96.3%	$631K-21.4%	$803K+148.2%	$324K+100.4%	$161K	$3K
Non-Current Liabilities	$184K-33.0%	$275K-21.3%	$350K-93.4%	$5.3M-57.1%	$12.3M	$0-100.0%	$63K	$0-100.0%	$826K+43.4%	$576K	$0	$0	$0	$0
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	$63K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$10.3M-46.0%	$19.0M+22.6%	$15.5M+1.1%	$15.3M+317.9%	$3.7M-27.3%	$5.1M+123.5%	-$21.5M-1108.9%	$2.1M+1816.3%	$111K-90.4%	$1.2M-39.6%	$1.9M+3640.2%	-$54K-131.6%	$171K	$357K
Retained Earnings	-$374.3M-6.3%	-$352.1M-5.4%	-$334.2M-11.0%	-$301.2M-20.0%	-$251.0M-11.6%	-$224.9M-448.0%	-$41.0M-465.1%	-$7.3M-52.3%	-$4.8M-104.2%	-$2.3M-132.5%	-$1.0M-75.5%	-$572K	N/A	N/A

Metric	Q4'2610-K	Q3'2610-K	Q2'2610-K	Q1'2610-K	Q4'2510-K	Q3'2510-K	Q2'2510-K	Q1'2510-K
Total Assets	$14.3M-33.9%	$17.5M-29.0%	$22.5M-12.4%	$26.8M+26.3%	$21.6M-14.5%	$24.7M-22.4%	$25.7M+19.6%	$21.2M-10.6%
Current Assets	$13.6M-34.1%	$16.9M-28.8%	$21.8M-11.7%	$26.0M+29.2%	$20.7M-13.9%	$23.7M-22.3%	$24.7M+20.0%	$20.2M-11.5%
Cash & Equivalents	$9.0M-48.8%	$13.1M-43.4%	$20.5M-15.8%	$25.0M+24.7%	$17.5M-26.4%	$23.2M-23.7%	$24.4M+20.7%	$20.0M-5.6%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$346K0.0%	$346K0.0%	$346K0.0%	$346K0.0%	$346K0.0%	$346K0.0%	$346K0.0%	$346K0.0%
Total Liabilities	$4.0M+56.1%	$1.9M-32.9%	$3.2M+82.8%	$1.9M-73.5%	$2.6M-73.7%	$2.8M-77.9%	$1.8M-87.3%	$7.2M-55.8%
Current Liabilities	$3.8M+66.9%	$1.7M-33.5%	$3.0M+106.3%	$1.6M-75.9%	$2.3M-75.7%	$2.5M-79.6%	$1.5M-89.6%	$6.8M-48.2%
Non-Current Liabilities	$184K-33.0%	$213K-27.9%	$233K-26.2%	$254K-23.5%	$275K-21.3%	$296K-19.3%	$315K+1688.9%	$333K-88.9%
Total Equity	$10.3M-46.0%	$15.6M-28.5%	$19.3M-19.5%	$24.9M+77.2%	$19.0M+22.6%	$21.8M+15.3%	$23.9M+219.3%	$14.1M+86.4%
Retained Earnings	-$374.3M-6.3%	-$368.6M-5.7%	-$363.3M-5.1%	-$357.3M-5.5%	-$352.1M-5.4%	-$348.7M-5.9%	-$345.9M-8.0%	-$338.7M-8.6%

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Long-Term Debt.

BIVIW Cash Flow Statement

BIVIW quarterly cash flow statement

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1410-K
Operating Cash Flow	-$19.0M0.0%	-$19.0M+31.9%	-$27.9M+30.6%	-$40.3M-112.0%	-$19.0M-81.7%	-$10.5M-542.0%	-$1.6M+34.9%	-$2.5M-302.6%	-$621K+0.4%	-$624K-305.9%	-$154K-135.0%	-$65K+62.2%	-$173K	-$163K
Stock-Based Compensation	$2.3M+91.0%	$1.2M-57.7%	$2.8M-33.1%	$4.2M-27.3%	$5.8M+92.3%	$3.0M+12054.1%	$25K-61.7%	$65K-72.8%	$238K	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	$14.5M+201.6%	-$14.3M	N/A	N/A	N/A	N/A	N/A	N/A	$10K	N/A	N/A	N/A
Financing Cash Flow	$10.5M-17.8%	$12.7M-28.5%	$17.8M-67.8%	$55.4M+67.2%	$33.1M+121.9%	$14.9M+1026.2%	$1.3M-52.6%	$2.8M+322.3%	$662K+31.1%	$505K+10100080.0%	-$5	N/A	N/A	$508K
Dividends Paid	$44K-88.2%	$369K-58.3%	$886K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'2610-K	Q3'2610-K	Q2'2610-K	Q1'2610-K	Q4'2510-K	Q3'2510-K	Q2'2510-K	Q1'2510-K
Operating Cash Flow	-$4.1M+26.5%	-$7.4M-493.7%	-$4.4M+48.3%	-$3.0M+15.5%	-$5.6M-40.0%	-$1.3M+78.6%	-$8.6M-45.3%	-$3.6M+70.6%
Stock-Based Compensation	N/A	N/A	N/A	$268K+125.7%	N/A	N/A	N/A	$119K-85.3%
Financing Cash Flow	$0	$0	$0-100.0%	$10.5M+4440.4%	$0+100.0%	$0-100.0%	$13.0M+163.5%	-$241K+59.4%
Dividends Paid	N/A	N/A	N/A	$44K-86.6%	$0	$0	$44K	$325K

Not reported in any period shown, so not listed: Depreciation & Amortization, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Share Buybacks.

BIVIW Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BIVIW quarterly financial ratios

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1410-K
Return on Equity	-214.9%-122.7pp	-92.3%+114.9pp	-207.1%+120.5pp	-327.6%+383.0pp	-710.6%	N/A	N/A	-114.7%+2074.3pp	-2189.0%-2074.0pp	-115.0%-92.4pp	-22.5%	N/A	-187.8%	-46.5%
Return on Assets	-154.9%-73.5pp	-81.4%+46.1pp	-127.4%+15.7pp	-143.2%-13.5pp	-129.7%	N/A	N/A	-95.0%+16.9pp	-111.9%-55.6pp	-56.3%-40.4pp	-15.9%+70.6pp	-86.5%+10.2pp	-96.7%	-46.2%
Current Ratio	3.59-5.5x	9.10+6.5x	2.57+0.2x	2.35-2.2x	4.50-0.1x	4.62+4.6x	0.02-1.5x	1.52+1.5x	0.040.0x	0.01-0.2x	0.16-0.7x	0.83-1.2x	2.06	143.81
Debt-to-Equity	0.39+0.3x	0.13-0.5x	0.63-0.7x	1.29-3.2x	4.48+4.3x	0.20	N/A	0.21-18.4x	18.56+17.5x	1.04+0.6x	0.42	N/A	0.94	0.01

Metric	Q4'2610-K	Q3'2610-K	Q2'2610-K	Q1'2610-K	Q4'2510-K	Q3'2510-K	Q2'2510-K	Q1'2510-K
Return on Equity	N/A	-33.8%-21.0pp	-31.5%-1.8pp	-20.4%+9.1pp	N/A	-12.8%+29.8pp	-29.7%+82.4pp	-29.5%+112.4pp
Return on Assets	N/A	-30.1%-18.8pp	-27.0%+0.7pp	-19.0%+0.6pp	N/A	-11.3%+14.1pp	-27.7%+11.4pp	-19.6%+25.5pp
Current Ratio	3.59-5.5x	9.97+0.7x	7.25-9.7x	15.83+12.9x	9.10+6.5x	9.32+6.9x	16.94+15.5x	2.95+1.2x
Debt-to-Equity	0.39+0.3x	0.120.0x	0.17+0.1x	0.08-0.4x	0.13-0.5x	0.13-0.5x	0.07-1.8x	0.51-1.6x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Asset Turnover, FCF Margin.

Where Biovie Inc Ranks

Frequently Asked Questions

Is Biovie Inc profitable?

No, Biovie Inc (BIVIW) reported a net income of -$22.1M in fiscal year 2026.

What is Biovie Inc's return on equity (ROE)?

Biovie Inc (BIVIW) has a return on equity of -214.9% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is Biovie Inc's operating cash flow?

Biovie Inc (BIVIW) recorded an outflow of $19.0M in operating cash flow during fiscal year 2026, representing cash used by core business activities.

What are Biovie Inc's total assets?

Biovie Inc (BIVIW) had $14.3M in total assets as of fiscal year 2026, including both current and long-term assets.

How much does Biovie Inc spend on research and development?

Biovie Inc (BIVIW) invested $14.0M in research and development during fiscal year 2026.

How many shares does Biovie Inc have outstanding?

Biovie Inc (BIVIW) had 8M shares outstanding as of fiscal year 2026.

What is Biovie Inc's current ratio?

Biovie Inc (BIVIW) had a current ratio of 3.59 as of fiscal year 2026, which is generally considered healthy.

What is Biovie Inc's debt-to-equity ratio?

Biovie Inc (BIVIW) had a debt-to-equity ratio of 0.39 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Biovie Inc's return on assets (ROA)?

Biovie Inc (BIVIW) had a return on assets of -154.9% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is Biovie Inc's Piotroski F-Score?

Biovie Inc (BIVIW) has a Piotroski F-Score of 1 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Biovie Inc's earnings high quality?

Biovie Inc (BIVIW) reported a net loss of $22.1M while operations used $19.0M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Biovie Inc cover its interest payments?

Biovie Inc (BIVIW) reported an operating loss of $22.7M against $18K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.